Companies: 10,795·Total market cap: $144.5T
CytoDyn Inc.

CytoDyn Inc.

CYDYOTCHealthcare● Active
$0.30
+$0.01(+2.15%)
Market Cap$409139434
P/E Ratio—
52W High$0.4
52W Low$0.21
Overview
Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

CytoDyn Inc. (CYDY) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CYDY · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.03cydy eps ttm · cydy earnings per shareEarnings history
PE Ratio (TTM)—cydy pe ratio ttm · cydy price to earningsPE Ratio deep dive
Revenue (TTM)$-5.9Mcydy revenue ttm · cydy annual revenueFull revenue history
Dividend YieldNo Dividenddoes cydy pay dividends · cydy dividend yieldDividend history
Shares Outstanding1.21Bcydy shares outstanding · cydy floatShares outstanding history
Next EarningsJul 29, 2026Est.cydy earnings date · cydy next earningsEarnings history

Explore CytoDyn Inc. Data

cydy stock data · financials
Market Cap$409.1Mcydy market cap · cydy valuation
Analyst Forecast$— · Buy
DividendsNo Dividenddoes cytodyn inc. pay dividends · cydy dividend yield
Revenue—cytodyn inc. annual revenue · cydy revenue
EarningsEPS $0.00+103.59%cydy earnings · cydy eps
PE Ratio—cydy pe ratio · cydy price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue-$5.9M
202320242025
cytodyn inc. revenue · cydy revenue 2025
FY 2025Net Income$3.7M▲ +107.51% YoY
202320242025
cytodyn inc. net income · cydy profit 2025
FY 2025EPS$0.00▲ +103.59% YoY
202320242025
cydy eps · cytodyn inc. earnings per share 2025
TTM:Revenue: -$5.9MNet Income: -$38.8MEPS: $-0.03View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy2 analystsis cydy a buy · cydy analyst rating
Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$—Low
$0.30Current
$—Avg Target
$—High
cydy price target · cydy 12 month forecast

Total: 2 · Buy rate: 50.0%

Stock Performance

Full History
1D+2.15%
1W+0.23%
1M-9.48%
3M+31.59%
YTD+6.68%
1Y-14.27%
5Y-84.91%

About CytoDyn Inc.

CEOJacob Lalezari
IPO DateDec 13, 2006
Employees9
CountryUS
Websitecytodyn.com

CytoDyn Inc. functions as a biotechnology enterprise currently in its clinical development phase. The company primarily concentrates on crafting therapies for a variety of medical conditions, leveragi…

BiotechnologyHealthcareOTCUS

what is cytodyn inc. · cydy stock overview · cytodyn inc. company profile · who is cytodyn inc. ceo · cydy OTC · cytodyn inc. headquarters · cytodyn inc. business segments

About Stock Overview & Key Data

CytoDyn Inc. (CYDY) is a Healthcare company in the Biotechnology industry, listed on OTC since Dec 13, 2006. As of the latest trading session, CYDY stock price is $0.30, with a market capitalization of $409.1M. The stock has returned -14.27% over the past 12 months and +6.68% year-to-date.

According to 2 Wall Street analysts, the consensus rating for CytoDyn Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, CytoDyn Inc. reported revenue of -$5.9M and net income of $3.7M. For detailed data — including CytoDyn Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, CytoDyn Inc. (CYDY) stock price is $0.30. The stock is traded on OTC under the ticker symbol CYDY. The 52-week range is $0.21 – $0.40.

CYDY stock priceCYDY quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice